UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open-label study

Lowrie, M; Thomson, S; Bessant, C; Sparkes, A; Harvey, RJ; Garosi, L; (2015) Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open-label study. Journal of Feline Medicine and Surgery , 19 (2) pp. 200-206. 10.1177/1098612X15622806. Green open access

[thumbnail of Lowrie et al_1475128_levetiracetam_in_the_management_2016.pdf]
Preview
Text
Lowrie et al_1475128_levetiracetam_in_the_management_2016.pdf - Accepted Version

Download (208kB) | Preview

Abstract

OBJECTIVES: Currently, there are no published randomised, controlled veterinary trials evaluating the efficacy of antiepileptic medication in the treatment of myoclonic seizures. Myoclonic seizures are a hallmark of feline audiogenic seizures (FARS). METHODS: This prospective, randomised, open-label trial compared the efficacy and tolerability of levetiracetam (20-25 mg/kg q8h) with phenobarbital (3-5 mg/kg q12h) in cats with suspected FARS that experienced myoclonic seizures. Cats were included that had ⩾12 myoclonic seizure days during a prospective 12 week baseline period. This was followed by a 4 week titration phase (until a therapeutic serum concentration of phenobarbital was achieved) and a 12 week treatment phase. RESULTS: Fifty-seven cats completed the study: 28 in the levetiracetam group and 29 in the phenobarbital group. A reduction of ⩾50% in the number of myoclonic seizure days was seen in 100% of patients in the levetiracetam group and in 3% of patients in the phenobarbital group (P <0.001) during the treatment period. Levetiracetam-treated cats had higher freedom from myoclonic seizures (50.0% vs 0%; P <0.001) during the treatment period. The most common adverse events were lethargy, inappetence and ataxia, with no difference in incidence between levetiracetam and phenobarbital. Adverse events were mild and transient with levetiracetam but persistent with phenobarbital. CONCLUSIONS AND RELEVANCE: These results suggest that levetiracetam is an effective and well-tolerated treatment for cats with myoclonic seizures and is more effective than phenobarbital. Whether it will prevent the occurrence of generalised tonic-clonic seizures and other forebrain signs if used early in the course of FARS is not yet clear.

Type: Article
Title: Levetiracetam in the management of feline audiogenic reflex seizures: a randomised, controlled, open-label study
Open access status: An open access version is available from UCL Discovery
DOI: 10.1177/1098612X15622806
Publisher version: http://dx.doi.org/10.1177/1098612X15622806
Language: English
Additional information: Copyright © The Author(s) 2015.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Life Sciences > UCL School of Pharmacy
URI: https://discovery.ucl.ac.uk/id/eprint/1475128
Downloads since deposit
405Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item